FeesSafety
Pluang+

Pfizer's new drugs boost revenue 32%, supports strong 6% dividend despite patent challenges.

Market News
21 Nov 2026, 05:15 WIB
Reuben Gregg Brewer
View Source
Bullish
Pfizer's new drugs boost revenue 32%, supports strong 6% dividend despite patent challenges.

Pfizer is navigating typical pharmaceutical challenges like patent expirations on key drugs but is seeing a 32% revenue increase from new and acquired products. The company remains financially strong with $1.8 billion in cash and $12.4 billion in short-term investments, supporting its large 6.1% dividend yield. Although earnings currently don't cover the dividend due to one-time charges, cash flow and management commitment back its continuation. Pfizer's attractive valuation and ongoing drug development efforts make it a compelling stock despite investor skepticism.

Pfizer's stock price on Pluang is USD 27.41 as of Nov 21, 2026 06:12 WIB, trading closer to its 52-week low of USD 23.67 than its high of USD 30.79. Despite a strong dividend yield of 6.25%, the platform shows a heavy sell bias with 88% of orders to sell versus 12% to buy. This contrasts with Pfizer's reported 32% revenue growth from new and acquired drugs, highlighting cautious investor sentiment on Pluang.

More News (PFE)

Pfizer shows strong new drug growth and backs a 6% dividend despite patent challenges.

Pfizer shows strong new drug growth and backs a 6% dividend despite patent challenges.

Pfizer is navigating typical pharmaceutical challenges like patent expirations on key drugs but is offsetting revenue losses with a 32% rise in sales from new and acquired products. The company maintains a strong financial position with $1.8 billion ...

Market News
Bullish
5 hours ago
Five high-yield dividend stocks under $50 offer retirees reliable income across diverse sectors.

Five high-yield dividend stocks under $50 offer retirees reliable income across diverse sectors.

Five dividend stocks trading under $50 per share—Verizon, Kinder Morgan, Pfizer, KeyCorp, and NNN REIT—offer retirees attractive yields backed by strong cash flow and earnings coverage. Verizon leads with a 6.07% yield supported by rising free cash f...

Bullish
12 hours ago
Three dividend stocks yield more than the 1-year Treasury bill, offering higher income with some risk.

Three dividend stocks yield more than the 1-year Treasury bill, offering higher income with some risk.

Pfizer, British American Tobacco, and Enbridge offer dividend yields of 6.25%, 5.81%, and 5.91% respectively, all exceeding the 4.59% yield of the 1-year Treasury bill as of November 2026. These stocks provide income from diverse sectors—healthcare, ...

Bullish
13 hours ago
Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer will pay its 352nd consecutive quarterly dividend on December 7, 2026, maintaining a strong track record for investors. The company faces challenges like a patent cliff, costly acquisitions, and clinical setbacks that could threaten this strea...

Company Fundamentals
Neutral
1 day ago
Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite patent cliff risks.

Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite patent cliff risks.

Pfizer will pay its 352nd consecutive quarterly dividend on December 7, 2026, maintaining a long-standing payout streak. Although the company faces challenges like a patent cliff, costly acquisitions, and clinical trial setbacks, it currently has eno...

Company Fundamentals
Neutral
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App